David Gerring
Corporate Officer/Principal bei ARECOR THERAPEUTICS PLC
Vermögen: 264 284 $ am 30.04.2024
Aktive Positionen von David Gerring
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Karriereverlauf von David Gerring
Statistik
International
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- David Gerring
- Erfahrung